SAVE 10% OFF First Order With Coupon Code: WELCOME10
Our Price: $149.99

Step 1
The customer picks the required Basaglar dosage and quantity and adds the item to the cart. Additional diabetes supplies can be added as needed.
Step 2
Patients must upload a clear photo or PDF during checkout for all prescription medications.
Step 3
A licensed pharmacist reviews the order and verifies the prescription.
Step 4
The order is packed in temperature-controlled packaging - such as insulated boxes with ice packs - to maintain its integrity during transit once it is approved. Delivery typically takes 3-5 business days.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Basaglar is a long-acting insulin used to help people with type 1 and type 2 diabetes maintain steady blood sugar control. Many patients choose to purchase Basaglar from Canada because prices can be up to 80% lower than typical U.S. pharmacy costs. Thousands of patients across the U.S. trust Insulin Outlet for its convenient online ordering process for a huge selection of name-brand diabetes medications at more affordable price points. A valid prescription is still required. Insulin Outlet partners only with licensed Canadian pharmacies and makes sure that all patients receive authentic and safely handled medication at a more affordable price.
| Active Ingredient | Insulin glargine |
|---|---|
| Type | Long-Acting |
| Manufacturer | Eli Lilly and Company |
| Onset | About 1–2 hours after injection |
| Duration | About 20–26 hours |
| Form | Injectable pen (KwikPen or Tempo Pen) |
| Origin | U.S. |
| Uses | Blood sugar control in adults and children with type 1 diabetes and adults with type 2 diabetes |
| Administration | Subcutaneous injection using a prefilled pen |
| Dosage | Varies based on patient needs and blood glucose levels |
| Dosage Frequency | Once daily (at the same time each day) |
| Storage |
|
This medication is a long-acting type of insulin that is prescribed to adults and children with type 1 diabetes. It is also prescribed to adults with type 2 diabetes. Basaglar is used to help these patients keep their blood glucose at healthy levels. This medication is delivered in the form of an injectable pen and is instructed to be used daily – at the same time each day.
Basaglar is available in U-100 (or 100 units/mL) strengths only. Patients specific dose of this medication may vary and is determined individually by their healthcare provider. Patients should take their doses at the same time each day unless their healthcare provider instructs them to do otherwise. This can be done by either using a KwikPen or a Tempo Pen.
Some additional reminders include:
Those taking this medication should make sure to never share their pens – regardless of whether or not a new needle is being used. Any changes to the patient’s insulin medication must be done under medical supervision and be supported by frequent glucose checks.
This medication may lead to hypoglycemia in some cases. This makes it extra important to increase monitoring during dose changes or when another glucose medication is being used. The same goes for when meal routines or activity levels shift and in patients with kidney or liver issues or reduced hypoglycemia awareness. Hypoglycemia may also occur if the wrong insulin is being used. The label of the medication should be confirmed before use of the medication.
Using Basaglar with thiazolidinediones may cause or worsen heart failure. Watch for symptoms and lower the dose or discontinue therapy if needed. Patients should also make sure to keep track of their potassium levels on this medication. Pens for this medication should never be shared between patients under any circumstances.
Patients taking Basaglar could experience several different side effects. The most common of these effects include:
Hypoglycemia may also occur in patients taking this medication and can be serious. It is important for patients to look out for signs of low blood sugar. They should also refrain from taking this medication if they are experiencing any symptoms of low blood sugar.
Patients experiencing low blood sugar while taking this medication may experience side effects like:
Patients experiencing any of these side effects or having an allergic reaction to the medication should seek medical attention immediately.
Missed doses or underdosing of this medication may lead to blood sugar levels becoming too high. Patients should routinely monitor their blood sugar to make sure this does not happen. Doses of this medication should still never be doubled in order to make up for any missed doses. Taking too much of this medication can have the opposite effect and cause blood sugar levels to become dangerously low.
The insulin pens for this medication should be kept in the refrigerator – between 36°F and 46°F (or between 2°C and 8°C). These pens are not meant to be frozen and should not be used if they do become frozen. Pens of this medication that have been opened may be stored at room temperature for a maximum of 28 days. These pens still should not be stored at temperatures greater than 86°F (30°C).
| Insulin | Type | Manufacturer | Duration | Concentration | Injection Device |
|---|---|---|---|---|---|
| Basaglar | Long-acting | Eli Lilly and Company | About 24 hours | 100 units per 1 mL | KwikPen or Tempo Pen |
| Lantus | Long-acting | Sanofi | Up to 24 hours | 100 units per 1 mL | Vial or SoloStar pen |
| Toujeo | Long-acting | Sanofi | Up to 36 hours | 300 units per 1 mL | SoloStar or Max Solostar pen |
Patients buying their medication from Insulin Outlet experience:
Buy Basaglar from Canada today.
Yes. Basaglar is a prescription-only insulin. A valid prescription must be uploaded during checkout before the pharmacy can process or ship the patient’s order.
Most Basaglar orders arrive within 3-5 business days once the prescription has been verified. Orders are shipped with temperature-controlled packaging to protect the medication during transit.
These medications are the same as long as the patient is purchasing the product that is manufactured by Eli Lilly. Both formulations contain the same active ingredient – insulin glargine. The only differences between the two medications are their packaging and pricing.
The exact dose depends on the type of diabetes for which the medication is being used for. It also may depend on factors such as age and weight. This is often anywhere from 0.2 units per kg up to 10 units per day.
Both Basaglar and Lantus are made with insulin glargine. This insulin is designed to provide long-acting glucose control. However, they are made by different manufacturers and come in different injection devices.
Pens should be refrigerated and kept within the 36°F to 46°F range prior to use. This is equivalent to being stored at temperatures between 2°C and 8°C. Basaglar pens can be kept at room temperature for up to 28 days – not exceeding 86°F (30°C) – once opened. Pens should not be used if they were ever frozen or exposed to excessive heat.
Disclaimer: The information provided on this page is for educational and informational purposes only and is not intended to replace professional medical advice or treatment. Basaglar is a prescription medication that must be used exactly as directed by a licensed healthcare provider.
BASAGLAR KWIKPEN. (n.d.). DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae
Basaglar® KwikPen®. (2025, April 24). Fairview Physician Associates Network. https://www.fpanetwork.org/device/basaglar-kwikpen/
Beabout, L.. (2025, May 22). Insulin prices: How much does insulin cost? SingleCare. https://www.singlecare.com/blog/insulin-prices/
Billingsley, A. (2024, February 20). Toujeo vs. Lantus: 6 Differences You Should Know. GoodRx. https://www.goodrx.com/conditions/diabetes-type-1/toujeo-vs-lantus
Brewer, A. (2025, July 16). Basaglar (insulin glargine) dosing schedule and details. https://www.medicalnewstoday.com/articles/drugs-basaglar-dosage#dosage-overview
Details for: BASAGLAR. (2025, December 8). Drug and Health Products Portal. https://dhpp.hpfb-dgpsa.ca/dhpp/resource/93005
Consumer information for: BASAGLAR. (2025, December 9). Drug and Health Products Portal. https://dhpp.hpfb-dgpsa.ca/dhpp/resource/93006/consumer-information
Highlights of Prescribing Information. (2021). Lilly and Company. https://pi.lilly.com/us/basaglar-uspi.pdf
Instructions for Use. (2022, August 26). Lilly. https://pi.lilly.com/ca/basaglar-80u-ca-ifu-kp.pdf
Long Acting Insulin For Diabetes | Lantus® (insulin glargine injection) 100 Units/mL. (n.d.). https://www.lantus.com/
TOUJEO® U-300 (insulin glargine) injection, for subcutaneous use Prescribing Information. (n.d.). Sanofi. https://products.sanofi.us/toujeo/toujeo.html
Related Products
How would you like to contact us?
Table Of Contents
×As we enter the warmer summer months, we are making minor adjustments to our shipping protocols to ensure you receive your medications in the best possible condition.
Due to higher seasonal temperatures during transit, we are implementing the following changes:
Why are we doing this?
While these medications are generally stable at room temperature for 15 to 30 days, shorter shipping cycles and increased insulation mitigate heat exposure. These proactive steps significantly reduce the need for reshipments and guarantee your medication arrives safely.